Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$24.9 - $40.26 $10,582 - $17,110
-425 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$45.7 - $81.86 $18,508 - $33,153
-405 Reduced 48.8%
425 $34,000
Q3 2019

Nov 07, 2019

BUY
$45.35 - $57.91 $18,366 - $23,453
405 Added 95.29%
830 $40,000
Q2 2019

Dec 03, 2019

BUY
$52.6 - $63.29 $22,355 - $26,898
425 New
425 $22,000
Q2 2019

Jul 30, 2019

SELL
$52.6 - $63.29 $22,355 - $26,898
-425 Closed
0 $0
Q1 2019

Dec 03, 2019

BUY
$39.99 - $53.48 $16,995 - $22,729
425 New
425 $22,000
Q1 2019

May 10, 2019

SELL
$39.99 - $53.48 $16,995 - $22,729
-425 Closed
0 $0
Q4 2018

Dec 03, 2019

BUY
$31.54 - $46.67 $13,404 - $19,834
425 New
425 $17,000
Q4 2018

Jan 31, 2019

SELL
$31.54 - $46.67 $13,404 - $19,834
-425 Closed
0 $0
Q3 2018

Dec 03, 2019

BUY
$38.0 - $51.1 $16,150 - $21,717
425 New
425 $16,000
Q3 2018

Nov 14, 2018

SELL
$38.0 - $51.1 $16,150 - $21,717
-425 Closed
0 $0
Q2 2018

Dec 03, 2019

BUY
$38.7 - $50.15 $16,447 - $21,313
425 New
425 $19,000
Q2 2018

Aug 03, 2018

SELL
$38.7 - $50.15 $16,447 - $21,313
-425 Closed
0 $0
Q1 2018

Dec 03, 2019

BUY
$39.6 - $65.9 $16,830 - $28,007
425 New
425 $21,000
Q1 2018

May 09, 2018

SELL
$39.6 - $65.9 $16,830 - $28,007
-425 Closed
0 $0
Q4 2017

Dec 03, 2019

BUY
$29.7 - $45.7 $12,622 - $19,422
425
425 $17,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.